ArticleJGH open : an open access journal of gastroenterology and hepatology2021
Factors predicting major complications, mortality, and recovery in percutaneous endoscopic gastrostomy.
Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Factors Associated with Mortality after Percutaneous Endoscopic Gastrostomy.JSLS : Journal of the Society of Laparoendoscopic SurgeonsPooled it
- Intragastric Localization as a Determinant of Peg Complications: A Comparative Analysis of Proximal and Distal Placements.Medicina (Kaunas, Lithuania) · 2026Article
- Is Percutaneous Endoscopic Gastrostomy an Innocent Procedure? A Retrospective Single-Center Study.Medicina (Kaunas, Lithuania) · 2025Article
- Percutaneous Endoscopic Gastrostomy in the 21st Century-An Overview of 1415 Consecutive Dysphagic Adult Patients.Nutrients · 2025Article
- Association between controlling nutritional status score and mortality in older patients with dysphagia in Japan:Frontiers in nutrition · 2025Article
- Time trends and outcomes of gastrostomy placement in a Swedish national cohort over two decades.World journal of gastroenterology · 2024Article
- Article
- Association between the C-reactive protein/albumin ratio and mortality in older Japanese patients with dysphagia.Frontiers in nutrition · 2024Article
- Preprocedural control of nutritional status score and prediction of early death after percutaneous endoscopic gastrostomy.JGH open : an open access journal of gastroenterology and hepatology · 2023Article
- Mortality and complications after percutaneous endoscopic gastrostomy: a retrospective multicentre study.BMC gastroenterology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimPercutaneous endoscopic gastrostomy (PEG) has been used in patients with dysphagia and inadequate food intake via an oral route. Despite being a procedure with a high success rate, complications and death have been reported. The aim was to identify the factors related to major complications and mortality, as well as PEG removal prognostic factors due to improvement of their general condition.
methodsPatient characteristics, comorbidities, laboratory data, concomitant medication, sedation, and indication for PEG placement were collected. Major complications, mortality, and PEG removal factors were assessed.
resultsA total of 388 patients were enrolled. There were 15 (3.9%) cases of major complications, with major bleeding being the most frequent in 6 (1.5%) patients. Corticosteroids were the independent variable associated with major complications (odds ratio [OR] 5.85; 95% confidence interval [CI] 1.71-20;
conclusionsChronic corticosteroid users potentially present with major complications. Low albumin levels and elevated CRP were associated with death. Previous aspiration pneumonia was a factor associated with permanent use of PEG; however, patients with oncological indication were the most benefited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.